Vaccine comprising a PCV2 ORF2 protein of genotype 2b
AssigneeIntervet Inc.
InventorsMelanie Sno, Erik Cox, Ruud Philip Antoon Maria Segers
Life of this patent
Estimating the term…
Abstract
The present invention pertains to a vaccine comprising an ORF2 encoded protein of porcine circo virus 2 (PCV2) and a pharmaceutically acceptable carrier, for use in a method to protect a pig against an infection with porcine circo virus type 2 by administering the vaccine to the pig, wherein the vaccine comprises less than 20 μg per dose of the ORF2 encoded protein, the protein being of a porcine circo virus of genotype 2b.
Claims8
A method of protecting a pig against an infection with porcine circo virus type 2, comprising administering to the pig a vaccine comprising an ORF2 encoded protein of porcine circo virus 2 (PCV2) and a pharmaceutically acceptable carrier, wherein the vaccine comprises less than 20 μg per dose of the ORF2 encoded protein, wherein the protein is of a porcine circo virus of genotype 2b;
- and wherein the vaccine provides protection against PCV2 of genotype 2d at a level corresponding to the protection conferred when the pig is vaccinated with an ORF2 encoded protein of PCV2d.
Dependencies are inferred from the claim text.